Megan E B Clowse

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. pmc The use of anti-TNFα medications for rheumatologic disease in pregnancy
    Megan Eb Clowse
    Division of Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Int J Womens Health 2:199-209. 2010
  2. doi request reprint Predictors of preterm birth in patients with mild systemic lupus erythematosus
    Megan E B Clowse
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Ann Rheum Dis 72:1536-9. 2013
  3. doi request reprint Pregnancy outcomes among patients with vasculitis
    Megan E B Clowse
    Duke University Medical Center, Durham, NC 27710, USA
    Arthritis Care Res (Hoboken) 65:1370-4. 2013
  4. ncbi request reprint Hydroxychloroquine in lupus pregnancy
    Megan E B Clowse
    Duke University Medical Center, Durham, North Carolina 27710, USA
    Arthritis Rheum 54:3640-7. 2006
  5. pmc Lupus activity in pregnancy
    Megan E B Clowse
    Division of Rheumatology and Immunology, Duke University Medical Center, Box 3535 Trent Drive, Durham, NC 27710, USA
    Rheum Dis Clin North Am 33:237-52, v. 2007
  6. pmc A national study of the complications of lupus in pregnancy
    Megan E B Clowse
    Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC 27710, USA
    Am J Obstet Gynecol 199:127.e1-6. 2008
  7. pmc Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis
    Megan E B Clowse
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Womens Health (Larchmt) 18:311-9. 2009
  8. pmc Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)
    Megan E B Clowse
    Duke University Medical Center, Durham, North Carolina, USA
    Arthritis Care Res (Hoboken) 63:1777-81. 2011
  9. ncbi request reprint Managing contraception and pregnancy in the rheumatologic diseases
    Megan E B Clowse
    Department of Rheumatology and Immunology Duke University Health System, Durham, UK
    Best Pract Res Clin Rheumatol 24:373-85. 2010
  10. doi request reprint The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus
    Megan E B Clowse
    Division of Rheumatology, Duke University Medical Center, Durham, North Carolina, USA
    J Rheumatol 38:1012-6. 2011

Detail Information

Publications18

  1. pmc The use of anti-TNFα medications for rheumatologic disease in pregnancy
    Megan Eb Clowse
    Division of Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Int J Womens Health 2:199-209. 2010
    ..Prior to using these medications during pregnancy, the risks and benefits of these drugs, other treatment options, and the ongoing inflammatory condition all must be carefully weighed by both doctor and patient...
  2. doi request reprint Predictors of preterm birth in patients with mild systemic lupus erythematosus
    Megan E B Clowse
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Ann Rheum Dis 72:1536-9. 2013
    ..Biomarkers that would identify at-risk pregnancies could allow interventions to prevent preterm birth...
  3. doi request reprint Pregnancy outcomes among patients with vasculitis
    Megan E B Clowse
    Duke University Medical Center, Durham, NC 27710, USA
    Arthritis Care Res (Hoboken) 65:1370-4. 2013
    ..Pregnancy outcomes of patients with vasculitis are unknown, but are of great concern to patients and physicians. Through an online survey, this study assessed pregnancy outcomes among patients with vasculitis...
  4. ncbi request reprint Hydroxychloroquine in lupus pregnancy
    Megan E B Clowse
    Duke University Medical Center, Durham, North Carolina 27710, USA
    Arthritis Rheum 54:3640-7. 2006
    ..The purpose of this study was to examine lupus activity and pregnancy outcomes in women with SLE treated or not treated with HCQ during pregnancy...
  5. pmc Lupus activity in pregnancy
    Megan E B Clowse
    Division of Rheumatology and Immunology, Duke University Medical Center, Box 3535 Trent Drive, Durham, NC 27710, USA
    Rheum Dis Clin North Am 33:237-52, v. 2007
    ..Fortunately, the majority of pregnancies in women with SLE are successful. However, the interaction between pregnancy and SLE activity can lead to complications for both mother and baby...
  6. pmc A national study of the complications of lupus in pregnancy
    Megan E B Clowse
    Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC 27710, USA
    Am J Obstet Gynecol 199:127.e1-6. 2008
    ..This study was undertaken to determine the risk of rare complications during pregnancy for women with systemic lupus erythematosus...
  7. pmc Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis
    Megan E B Clowse
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Womens Health (Larchmt) 18:311-9. 2009
    ..We performed a systematic review of studies examining whether a GnRHa administered during chemotherapy is protective of ovarian function and fertility...
  8. pmc Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)
    Megan E B Clowse
    Duke University Medical Center, Durham, North Carolina, USA
    Arthritis Care Res (Hoboken) 63:1777-81. 2011
    ..In this study, we assessed the rate of diminished ovarian reserve in women with GPA who received CYC versus methotrexate (MTX)...
  9. ncbi request reprint Managing contraception and pregnancy in the rheumatologic diseases
    Megan E B Clowse
    Department of Rheumatology and Immunology Duke University Health System, Durham, UK
    Best Pract Res Clin Rheumatol 24:373-85. 2010
    ..The expected post-partum arthritis flare may be avoided by restarting medications soon after delivery. Judicious use of medication and close observation may be the keys to successful pregnancy in women with rheumatologic disease...
  10. doi request reprint The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus
    Megan E B Clowse
    Division of Rheumatology, Duke University Medical Center, Durham, North Carolina, USA
    J Rheumatol 38:1012-6. 2011
    ..The importance of low complement and anti-dsDNA during pregnancy in patients with systemic lupus erythematosus (SLE) is poorly defined. We investigated the effect of these laboratory tests and clinical SLE activity on pregnancy outcomes...
  11. ncbi request reprint Early risk factors for pregnancy loss in lupus
    Megan E B Clowse
    Department of Medicine, Division of Rheumatology, Duke University Medical Center, Durham, NC 27110, USA
    Obstet Gynecol 107:293-9. 2006
    ..To identify early risk factors for pregnancy loss in lupus pregnancies...
  12. doi request reprint Depressive symptoms and associated factors in systemic lupus erythematosus
    David E Karol
    Duke University Medical Center, Durham, NC
    Psychosomatics 54:443-50. 2013
    ..Depressive symptoms affect anywhere from 11% to 71% of patients with systemic lupus erythematosus (SLE), which may be related to SLE disease activity, other clinical variables, or sociodemographic factors...
  13. doi request reprint Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents
    Robert D Tunks
    Division of Pediatric Cardiology, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
    Am J Obstet Gynecol 208:64.e1-7. 2013
    ..The importance of maternal autoantibody levels in congenital heart block and elucidation of maternal factors that may reduce disease burden require further clarification...
  14. doi request reprint Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus
    Megan E B Clowse
    Duke University Medical Center, Durham, North Carolina, USA
    Arthritis Care Res (Hoboken) 64:668-74. 2012
    ..We sought to determine the roles of infertility, pregnancy loss, and personal choice on family size in women with these diseases...
  15. pmc The management of rheumatic diseases in pregnancy
    K Mitchell
    Division of Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Scand J Rheumatol 39:99-108. 2010
    ..Therefore, continued immunosuppression with the least risky medications will allow for the most optimal pregnancy outcomes...
  16. doi request reprint Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis
    John R Crochet
    Division of Reproductive Endocrinology and Fertility, Department of Obstetrics and Gynecology, Duke University Hospital, Durham, North Carolina, USA
    Fertil Steril 95:1786.e13-6. 2011
    ..To report a case of late ovarian hyperstimulation syndrome (OHSS) in a woman with lupus nephritis undergoing controlled ovarian stimulation and in vitro fertilization (IVF) with subsequent transfer into a gestational surrogate...
  17. ncbi request reprint Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis
    Megan E B Clowse
    Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Rheumatol 30:1341-3. 2003
    ..This case illustrates the risk of severe digital ischemia and digital loss in patients with scleroderma during chemotherapy with carboplatin and gemcitabine...
  18. ncbi request reprint The impact of increased lupus activity on obstetric outcomes
    Megan E B Clowse
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Rheum 52:514-21. 2005
    ..Systemic lupus erythematosus is associated with multiple adverse pregnancy outcomes. We examined the impact of disease activity on spontaneous abortions, perinatal mortality, preterm delivery, and birth weight...